HeimSDZ • SWX
add
Sandoz Group AG
Við síðustu lokun
40,27 CHF
Dagbil
39,78 CHF - 40,54 CHF
Árabil
25,01 CHF - 41,16 CHF
Markaðsvirði
17,75 ma. CHF
Meðalmagn
963,72 þ.
V/H-hlutf.
-
A/V-hlutfall
1,12%
Aðalkauphöll
SWX
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 2,53 ma. | 2,68% |
Rekstrarkostnaður | 1,02 ma. | 7,11% |
Nettótekjur | 75,00 m. | -36,17% |
Hagnaðarhlutfall | 2,96 | -37,95% |
Hagnaður á hvern hlut | — | — |
EBITDA | 270,50 m. | -21,93% |
Virkt skatthlutfall | 25,98% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 701,00 m. | 451,97% |
Heildareignir | 19,32 ma. | 4,77% |
Heildarskuldir | 10,95 ma. | 9,80% |
Eigið fé alls | 8,37 ma. | — |
Útistandandi hlutabréf | 430,20 m. | — |
Eiginfjárgengi | 2,07 | — |
Arðsemi eigna | 2,15% | — |
Ávöxtun eigin fjár | 3,24% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 75,00 m. | -36,17% |
Handbært fé frá rekstri | 114,50 m. | 169,41% |
Reiðufé frá fjárfestingum | -197,00 m. | -110,70% |
Reiðufé frá fjármögnun | -114,00 m. | -240,74% |
Breyting á handbæru fé | -204,00 m. | -869,81% |
Frjálst peningaflæði | 102,88 m. | -35,27% |
Um
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland. Sandoz is one of the leading global generics businesses. Wikipedia
Framkvæmdastjóri
Stofnsett
1886
Vefsvæði
Starfsfólk
22.633
